China Animal Husbandry Industry Co., Ltd.

SHSE:600195 Stock Report

Market Cap: CN¥7.3b

China Animal Husbandry Industry Valuation

Is 600195 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 600195 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

CN¥2.59
Fair Value
176.2% overvalued intrinsic discount
3
Number of Analysts

Below Fair Value: 600195 (CN¥7.16) is trading above our estimate of fair value (CN¥2.59)

Significantly Below Fair Value: 600195 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 600195?

Key metric: As 600195 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 600195. This is calculated by dividing 600195's market cap by their current earnings.
What is 600195's PE Ratio?
PE Ratio81.4x
EarningsCN¥89.84m
Market CapCN¥7.31b

Price to Earnings Ratio vs Peers

How does 600195's PE Ratio compare to its peers?

The above table shows the PE ratio for 600195 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average76.9x
688799 Hunan Warrant PharmaceuticalLtd
61.2x22.64%CN¥7.5b
002907 Chongqing Pharscin Pharmaceutical
81.7xn/aCN¥6.8b
300584 Nanjing Hicin Pharmaceutical
150.8xn/aCN¥6.7b
000915 Shandong Wit Dyne HealthLtd
14.1x8.05%CN¥7.3b
600195 China Animal Husbandry Industry
81.4x43.01%CN¥7.3b

Price-To-Earnings vs Peers: 600195 is expensive based on its Price-To-Earnings Ratio (81.4x) compared to the peer average (76.9x).

Price to Earnings Ratio vs Industry

How does 600195's PE Ratio compare vs other companies in the CN Pharmaceuticals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
600195 81.4xIndustry Avg. 34.7xNo. of Companies26PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 600195 is expensive based on its Price-To-Earnings Ratio (81.4x) compared to the CN Pharmaceuticals industry average (34.7x).

Price to Earnings Ratio vs Fair Ratio

What is 600195's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

600195 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio81.4x
Fair PE Ratio35.5x

Price-To-Earnings vs Fair Ratio: 600195 is expensive based on its Price-To-Earnings Ratio (81.4x) compared to the estimated Fair Price-To-Earnings Ratio (35.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 600195 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCN¥7.16
CN¥7.87
+9.96%
3.41%CN¥8.12CN¥7.50n/a3
Sep ’26CN¥7.70
CN¥7.87
+2.25%
3.41%CN¥8.12CN¥7.50n/a3
Aug ’26CN¥7.60
CN¥7.87
+3.60%
3.41%CN¥8.12CN¥7.50n/a3
Jul ’26CN¥7.32
CN¥7.87
+7.56%
3.41%CN¥8.12CN¥7.50n/a3
Jun ’26CN¥6.97
CN¥7.87
+12.96%
3.41%CN¥8.12CN¥7.50n/a3
May ’26CN¥6.67
CN¥7.87
+18.04%
3.41%CN¥8.12CN¥7.50n/a3
Apr ’26CN¥6.71
CN¥7.95
+18.48%
5.66%CN¥8.40CN¥7.50n/a2
Mar ’26CN¥6.23
CN¥7.95
+27.61%
5.66%CN¥8.40CN¥7.50n/a2
Feb ’26CN¥6.43
CN¥7.95
+23.64%
5.66%CN¥8.40CN¥7.50n/a2
Jan ’26CN¥6.71
CN¥7.67
+14.26%
7.09%CN¥8.40CN¥7.10n/a3
Dec ’25CN¥7.17
CN¥7.67
+6.93%
7.09%CN¥8.40CN¥7.10n/a3
Nov ’25CN¥6.82
CN¥8.86
+29.91%
19.69%CN¥12.00CN¥7.10n/a5
Oct ’25CN¥7.23
CN¥8.74
+20.89%
20.50%CN¥12.00CN¥7.10CN¥7.165
Sep ’25CN¥6.13
CN¥8.74
+42.58%
20.50%CN¥12.00CN¥7.10CN¥7.705
Aug ’25CN¥6.60
CN¥10.48
+58.79%
19.20%CN¥12.50CN¥7.10CN¥7.605
Jul ’25CN¥7.65
CN¥11.30
+47.71%
15.74%CN¥13.80CN¥8.70CN¥7.326
Jun ’25CN¥8.77
CN¥11.62
+32.46%
14.87%CN¥13.80CN¥9.30CN¥6.976
May ’25CN¥8.82
CN¥11.62
+31.71%
14.87%CN¥13.80CN¥9.30CN¥6.676
Apr ’25CN¥9.73
CN¥13.72
+40.97%
22.55%CN¥18.90CN¥9.60CN¥6.716
Mar ’25CN¥9.54
CN¥14.20
+48.85%
17.85%CN¥18.90CN¥11.50CN¥6.236
Feb ’25CN¥9.02
CN¥14.20
+57.43%
17.85%CN¥18.90CN¥11.50CN¥6.436
Jan ’25CN¥11.86
CN¥14.20
+19.73%
17.85%CN¥18.90CN¥11.50CN¥6.716
Dec ’24CN¥11.47
CN¥14.20
+23.80%
17.85%CN¥18.90CN¥11.50CN¥7.176
Nov ’24CN¥11.14
CN¥14.38
+29.11%
16.46%CN¥18.90CN¥11.50CN¥6.826
Oct ’24CN¥11.29
CN¥14.50
+28.43%
16.23%CN¥18.90CN¥11.50CN¥7.236
CN¥7.87
Fair Value
9.1% undervalued intrinsic discount
3
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/04 13:07
End of Day Share Price 2025/09/30 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

China Animal Husbandry Industry Co., Ltd. is covered by 12 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zongjun ZHAOBOCI Research Ltd.
Siyang WangChina International Capital Corporation Limited
Wenjun CaiChina Stock Investment Research Co. Ltd. (GZ500..com)